Activity of datopotamab deruxtecan in TROP2-expressing low-grade serous ovarian cancer: a preclinical study

Sarah Ottum, Orazio De Tommasi, Cem Demirkiran, Stefania Bellone, Natalia Buza, Na Niu, Namrata Sethi, Tobias M. Hartwich, Alessandro D. Santin

Open source

DOI: 10.1016/j.gore.2026.102146
Published: 2026-08
Container: Gynecologic Oncology Reports
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.gore.2026.102146,
  title = {Activity of datopotamab deruxtecan in TROP2-expressing low-grade serous ovarian cancer: a preclinical study},
  author = {Sarah Ottum and Orazio De Tommasi and Cem Demirkiran and Stefania Bellone and Natalia Buza and Na Niu and Namrata Sethi and Tobias M. Hartwich and Alessandro D. Santin},
  year = {2026},
  journal = {Gynecologic Oncology Reports},
  doi = {10.1016/j.gore.2026.102146},
  url = {https://doi.org/10.1016/j.gore.2026.102146}
}

RIS

TY  - JOUR
TI  - Activity of datopotamab deruxtecan in TROP2-expressing low-grade serous ovarian cancer: a preclinical study
AU  - Sarah Ottum
AU  - Orazio De Tommasi
AU  - Cem Demirkiran
AU  - Stefania Bellone
AU  - Natalia Buza
AU  - Na Niu
AU  - Namrata Sethi
AU  - Tobias M. Hartwich
AU  - Alessandro D. Santin
PY  - 2026
JO  - Gynecologic Oncology Reports
DO  - 10.1016/j.gore.2026.102146
UR  - https://doi.org/10.1016/j.gore.2026.102146
ER  -

APA

Ottum, S., Tommasi, O. D., Demirkiran, C., Bellone, S., Buza, N., Niu, N., Sethi, N., Hartwich, T. M., & Santin, A. D. (2026). Activity of datopotamab deruxtecan in TROP2-expressing low-grade serous ovarian cancer: a preclinical study. Gynecologic Oncology Reports. https://doi.org/10.1016/j.gore.2026.102146

Source records

crossref · retrieved 2026-09-26T21:01:39.236Z